ScholarWorks@SUNGKYUNKWAN UNIVERSITY: RHEE, EUN JUNG

Detailed Information

RHEE, EUN JUNG (이은정)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diabetes mellitus:26||Obesity:17||Diabetes:12||Insulin resistance:11||Nonalcoholic fatty liver disease:11||Metabolic syndrome:9||Cardiovascular diseases:9||Coronary artery calcification:8||Atherosclerosis:7||Nonalcoholic fatty liver disease:6||Mortality:6||Diabetes mellitus, type 2:6||metabolic syndrome:5||Risk factors:5||body mass index:5||Heart failure:5||Prevalence:5||Diagnosis:5||Fatty liver:4||Osteoporosis:4||Body mass index:4||Dyslipidemias:4||obesity:4||Epidemiology:4||Waist circumference:4||Exendin4:4||Fact sheet:4||Endocrine system diseases:3||Prediabetes:3||Vascular calcification:3||Glycated hemoglobin:3||type 2 diabetes mellitus:3||Type 2 diabetes mellitus:3||vascular calcification:3||Inflammation:3||COVID19:3||Autophagy:3||Hypothyroidism:3||insulin resistance:3||Insulinsecreting cells:3||Hypertension:3||Type 2:3||Abdominal obesity:3||Sarcopenia:3||Glycemic progression:2||ER stress:2||Cardiovascular complication:2||Cardiovascular disease:2||nonalcoholic fatty liver disease:2||National Health Insurance Service:2||SIRT1:2||Cholesterol:2||Endocrinologists:2||Endoplasmic reticulum stress:2||Metformin:2||Physical activity:2||polymorphism:2||prediabetes:2||Pioglitazone:2||Retinoid:2||Waistheight ratio:2||Lipolysis:2||Lipoprotein(a):2||risk factor:2||risk factors:2||Weight cycling:2||Fatty acid oxidation:2||Exercise:2||Coronary artery calcium score:2||Practice guideline:2||albuminuria:2||Cardiovascular risk factors:2||AMPactivated protein kinases:2||thyroid hormones:2||Arterial stiffness:2||Hyperinsulinemia:2||Progression:2||Hyperthyroidism:2||Hypertriglyceridemia:2||Incidence:2||DPPIV inhibitor:2||Metabolic health:2||coronary artery disease:2||type 2 diabetes:2||Adrenal insufficiency:2||cardiovascular disease:2||waist circumference:2||Blood pressure:2||Adipocytes:2||Smoking:2||Severe acute respiratory syndrome coronavirus 2:2||Diabetic retinopathy:2||Glomerular filtration rate:2||Glucagonlike peptide1 receptor:2||Coronary artery disease:2||Renal insufficiency:2||Statin:2||Stroke:2||Intracranial arterial stenosis:2||AMPK:2||Therapeutics:2||Thiazolidinedione:2||Fibrosis:2||Thyroid:2||Clusterin:2||Cohort studies:2||Korea:2||Korean National Health Insurance Corporation:2||Treatment:2||cohort study:2||mortality:2||Hepatocytes:1||Hepatokine:1||Highsensitivity Creactive protein:1||Hip fractures:1||Hypertriglyceridemic waist phenotype:1||Hypertriglyericlemia:1||I:1||I123MIBG:1||INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE:1||Impaired fasting glucose:1||Incident diabetes:1||Incretins:1||Inorganic phosphate:1||Insulin:1||Insulin Resistance:1||Insulin infusion systems:1||Insulin secretion and incident diabetes:1||Insulin signaling:1||Insulinogenic index:1||Insurance:1||Intensive care unit:1||International Diabetes Federation:1||Intraabdominal fat:1||Journal:1||Juvenileonset open angle glaucoma:1||Kangaroomother care method:1||Keratitis medicamentosa:1||Key Words: Family history:1||Korean:1||Koreans:1||L:1||LC3II conversion:1||LDL:1||LXR:1||Lean mass:1||Left ventricular diastolic dysfunction:1||Life style:1||Lipid accumulation:1||Lipid profiles:1||Lipids:1||Lipin1:1||Liposlim (R) powerassisted liposuction:1||Liver cirrhosis:1||Lowdensity lipoprotein cholesterol:1||Lung Function:1||Lung function:1||METABOLIC EQUIVALENT TASK:1||MORTALITY:1||Macrovascular complication:1||Medication therapy management:1||Mental Disorder:1||Metab:1||Metabolic Syndrome:1||Metabolic syndrome crit:1||Metabolically healthy obesity:1||Metabolism:1||Microalbuminuria:1||Microvascular complication:1||Mitochondria:1||Muscle mass:1||NAD:1||NAFLD:1||National Health Insurance System:1||Neoplasm staging:1||New classification:1||Nicotinamide:1||Nicotinic acid:1||NonAlcoholic Fatty Liver Disease:1||NonObese older:1||Nonalcoholic steatohepatitis:1||Nutrition therapy:1||Obesity class:1||Optical coherence tomography:1||Osteoblast differentiation:1||Osteoclast:1||Osteoprotegerin:1||Ovarian neoplasms:1||Oxidative stress:1||PERK/eIF2α:1||PETCT:1||PET/CT:1||PGC1 alpha:1||PHYSICAL ACTIVITY:1||PPAR alpha:1||PPAR gamma polymorphism:1||PPARgamma:1||PPARgamma Pro12Ala:1||PTH:1||Palmitic acid:1||Pancreas:1||Percutaneous coronary intervention:1||Perilipin:1||Persistence:1||Persistent:1||Pharmacotherapy:1||Phosphate:1||Pituitary:1||Polycystic ovary syndrome:1||Polymorphism:1||Pooled Cohort Equation:1||Pooled cohort equation:1||PosnerSchlossman syndrome:1||Postprandial hyperglycemia:1||Prediabetic state:1||Premature infant:1||Primary health care:1||Prognosis:1||Prohibitin:1||Prospective:1||Public health:1||RANKL:1||RAR:1||RXR:1||Receptor activator of nuclear factorkappa B ligand (RANKL):1||Republic of Korea:1||Research:1||Retinal vessel:1||Retinopathy:1||Retrospec:1||Retrospective studies:1||Rexinoid:1||Rhegmatogenous retinal detachment:1||Risk:1||Risk factor for recurrence:1||SREBP1:1||SREBP1c:1||Sarcoma:1||Secondary prevention:1||Secondhand smoke:1||Selenoprotein P:1||Sex:1||Sirtuin:1||Sitagliptin:1||Sitagliptin phosphate:1||Skeletal muscle index:1||Smoking cessation:1||Social factors:1||Sodium hyaluronate:1||Sodiumglucose transporter 2 inhibitors:1||Sphingosine 1phosphate:1||Sphingosine kinase:1||Spinal fractures:1||Subclinical atherosclerosis:1||Subcutaneous fat, abdominal:1||Systemic Inflammation:1||Thiazolidinediones:1||Thyroid diseases:1||Toxic keratitis:1||Transcranial Doppler ultrasound:1||Transcranial doppler:1||Transferrin:1||Transient Liver Elastography:1||Treatment outcome:1||Tumor necrosis facto:1||Ty:1||Type 2 Diabetes:1||Underweight:1||Uterine cervix:1||VLDL assembly:1||Variability:1||Vascular smooth muscle cell:1||Vascular smooth muscle cells:1||Villoglandular adenocarcinoma:1||Visceral obesity:1||Visual field progression:1||Vitamin D:1||Weight:1||Weight change:1||White blood cell count:1||Yoyo effect:1||abdominal obesity:1||addon therapy:1||adiponectin:1||age:1||alkaline phosphatase:1||ambulatory glucose profile:1||anesthesia:1||antioxidants:1||apolipoprotein AI:1||atherosclerosis:1||autonomic nervous system:1||betaCell:1||body composition:1||bone:1||bone and bones:1||bone mineral density:1||bone turnover markers:1||chronic:1||chronic kidney disease:1||comorbidity:1||composite metric:1||continuous glucose monitor:1||coronary angiogram:1||coronary artery calcification:1||coronary artery calcium:1||coronary artery calcium score:1||diabetes:1||diabetes mellitus:1||diabetic nephropathies:1||diffuse thyroid uptake:1||disc hemorrhage:1||dosefinding study:1||dyslipidemia:1||extracellular signalregulated kinases 1 and 2:1||factual:1||fasting glucose:1||fasting hyperglycaemia:1||fatty liver disease (FLD):1||gammaGlutamyl transferase:1||gastrectomy:1||gemigliptin:1||genetic:1||glaucoma:1||glomerular filtration rate:1||glycated haemoglobin:1||glycemia risk index:1||heart rate variability:1||high blood pressure:1||homocysteine:1||hyperglycemia:1||hypertension:1||hyperthyroidism:1||hypoglycemia:1||hypothyroidism:1||incident diabetes mellitus:1||indicator:1||inflam:1||insulin sensitizer:1||international diabetes federation criteria:1||intracranial atherosclerosis:1||ischaemic stroke:1||largevolume liposuction:1||liver fibrosis:1||metabolic health:1||metformin:1||microalbuminuria:1||microvascular changes:1||middle age:1||monotherapy:1||myocardial infarction:1||myocardium:1||n:1||nationwide populationbased study:1||neonatal:1||neoplasms:1||norepinephrine:1||normaltension glaucoma:1||old age:1||optical coherence tomographyangiography:1||osteoporosis:1||osteoprotegerin:1||pancreatic beta cell:1||parasympathetic nervous system:1||prediction model:1||probucol:1||progression:1||renal function:1||restoration:1||retinopathy:1||sex:1||subclinical hyperthyroidism:1||subclinical hypothyroidism:1||subclinical thyroid dysfunction:1||superwet technique:1||sympathetic nervous system:1||teneligliptin:1||thyroid:1||thyroid cancer:1||thyroid dysfunction:1||thyroid neoplasms:1||thyroidstimulating hormone:1||thyrotropin:1||thyroxine:1||time in range:1||transcranial Doppler ultrasound:1||transporter:1||triiodothyronine:1||tumor:1||tumor necrosis factoralpha:1||type 2:1||urinary Cpeptide:1||visceral adiposity index:1||women:1||감마나이프 치료:1||뇌하수체:1||미숙아:1||신생아중환자실:1||육종:1||캥거루 케어:1||deoxyguanosine:1||프로토콜:1||.:1||1:1||1,5Anhydroglucitol (1,5AG):1||5anhydroglucitol:1||8Hydroxy2 &apos:1||ANGPTL8:1||Acarbose:1||Achievement:1||Acromegaly:1||Adipocytokine:1||Adiponectin:1||Aging:1||Alanine aminotra:1||Alanine aminotransferase:1||Alkaline phosphatase:1||Alogliptin:1||Angiography:1||AntiMullerian hormone:1||Aortic calcification:1||Apolipoprotein B/AI:1||Apoptosis:1||Arteriosclerosis:1||Artificial:1||Asian:1||Atrial fibrillation:1||Autophagy related protein 3:1||Bitter melon:1||Blood glucose selfmonitoring:1||Body com:1||Body composition:1||Body height:1||Body weight:1||Body weight changes:1||Body weight maintenance:1||Bone mineral density:1||Bone turnover marker:1||Cpeptide:1||Creactive protein:1||Calcification:1||Cancer:1||Cardiac st:1||Carotid artery:1||Chaperone:1||Cholesterol HDL:1||Cholesterol LDL:1||Cholesterol guidelines:1||Choroidal vascular hyperpermeability:1||Chronic:1||Chronic kidney disease:1||Cigarette smoke:1||Clinical protocols:1||Combination:1||Comorbidity:1||Coronary artery:1||Coronary artery calcification (CAC):1||Coronary vessels:1||Cotinine:1||DPP4 inhibitors:1||Daily calcium intake:1||Dapagliflozin:1||Databases:1||Depression:1||Diabetic nephropathies:1||Diabetic reti:1||Diet:1||Dietary cholesterol:1||Dipeptidylpeptidase IV inhibitors:1||Drug therapy:1||Dulaglutide:1||Dyslipidemia:1||ERAD:1||EXERCISE:1||Education:1||Eicosapentaenoic acid:1||Exercise benefit:1||Ezetimibe:1||F18FDG:1||FAM3A:1||FGF21:1||FGFRs:1||Farnesoid X receptor agonist:1||Fatty acidbinding protein4:1||Fatty liver disease:1||FetuinA:1||Fractures:1||Framingham Risk Score:1||Framingham risk score:1||Gamma knife radiosurgery:1||Glaucoma:1||Glimepiride:1||Glucolipotoxicity:1||Glucose:1||Glucose intolerance:1||Glucose tolerance:1||Glucose tolerance test:1||Glycated albumin:1||Glycemia:1||Glycemic control:1||Glycosylated hemoglobin:1||Growth hormonesecreting pituitary adenoma:1||Guideline:1||HDL cholesterol:1||HDL cholesterol/apolipoprotein AI ratio:1||HOMAIR:1||HPV infection:1||HbA1C:1||HbA1c:1||Helicobacter pylori:1||HepG2 cells:1||Hepatic steatosis:1||

STATISTICS: Total View :0; Today View :957

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE